Arti-Cell Forte injektionsvæske; forsyningsvanskelighed
Safety Classified by Officially
Der er aktuelle problemer med forsyningen af Arti-Cell Forte injektionsvæske, suspension fra Boehringer Ingelheim Animal Health Nordics A/S.
Produkt: Arti-Cell Forte injektionsvæske, suspension
Aktivt stof: Chondrogenisk inducerede equine allogeneiske mesenkymale stamceller af periferal blod-oprindelse (hestestamceller)
ATC-kode: QM09AX90
Forventet periode: Start august 2023 - slut maj 2027
Årsag: Kvalitetsproblemer
Virksomhed: Boehringer Ingelheim Animal Health Nordics A/S
This is an extract. The publication continues at the source.
Source: Lægemiddelstyrelsen.
Read the original at the source: https://laegemiddelstyrelsen.dk/da/godkendelse/kontrol-og-inspektion/mangel-paa-medicin/meddelelser-om-forsyning-af-medicin/veterinaer-2023/arti-cell-forte-injektionsvaeske-forsyningsvanskelighed/
Officially imported this from Lægemiddelstyrelsen’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Lægemiddelstyrelsen — imported from official source
- Official source
- https://laegemiddelstyrelsen.dk/da/Feeds/rss-feed/ RSS
- Imported
- October 20, 2026 12:33
- Versions
- 1 recorded
- Identity
-
3C02B4DE50574CD4BC97F4072BC08147